Akcea Announces Transition at the Top
- Posted by ISPE Boston
- On September 25, 2019
Boston-based Akcea Therapeutics, a majority-owned affiliate of Ionis Pharmaceuticals, has announced that its board of directors has appointed Damien McDevitt, Ph.D., a member of its board of directors, as interim chief executive officer, effective immediately. In addition, Michael J. Yang and Joseph ‘Skip’ Klein III have joined the Company’s board of directors. The company also […]
Read More